Skip to main content
logo
Aptus Pharma Limited (BOM:544529)
India flag India · Delayed Price · Currency is INR
297.20
+1.70 (0.58%)
At close: Aug 4, 2026

Aptus Pharma Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
465.75465.75245.58178.57138.97105.07
Revenue Growth
73.34%89.65%37.52%28.49%32.27%106.18%
Gross Profit
252.05252.05155.21110.3191.3566.76
Operating Income
70.3970.3945.8413.784.762.37
Net Income
46.246.2318.62.431.01
Earnings Per Share
3.113.112.552.291.330.55
EPS Growth
39.33%22.13%11.13%72.44%140.87%125.39%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
10.2710.2752.149.145.372.61
Total Debt
71.8271.82103.5753.0822.1212.58
Net Cash (Debt)
-61.55-61.55-51.43-43.94-16.75-9.98
Net Cash Growth
------
Net Cash Per Share
-4.15-4.15-4.23-11.71-9.17-5.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-68.6-68.6-18.38-21.75-1.81-
Capital Expenditures
-21.87-21.87-6.22-3.3-3.53-
Free Cash Flow
-90.46-90.46-24.6-25.04-5.34-
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
54.12%54.12%63.20%61.77%65.73%63.54%
Operating Margin
15.11%15.11%18.67%7.72%3.43%2.26%
Pretax Margin
13.69%13.69%17.08%6.52%2.40%1.39%
Profit Margin
9.92%9.92%12.62%4.82%1.75%0.96%
FCF Margin
-19.42%-19.42%-10.02%-14.02%-3.84%-

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
95.5051.85----
PS Ratio
10.945.14----